134 related articles for article (PubMed ID: 22949003)
1. A novel treatment of central serous chorioretinopathy with topical anti-inflammatory therapy.
Chong CF; Yang D; Pham TQ; Liu H
BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 22949003
[TBL] [Abstract][Full Text] [Related]
2. Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy.
Wuarin R; Kakkassery V; Consigli A; Roquelaure D; Papanastasiou A; Schutz JS; Thumann G; Chronopoulos A
Optom Vis Sci; 2019 Jul; 96(7):500-506. PubMed ID: 31274738
[TBL] [Abstract][Full Text] [Related]
3. A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
Lai FH; Ng DS; Bakthavatsalam M; Chan VC; Young AL; Luk FO; Tsang CW; Brelén ME
Am J Ophthalmol; 2016 Oct; 170():91-99. PubMed ID: 27519561
[TBL] [Abstract][Full Text] [Related]
4. Half-fluence photodynamic therapy in acute central serous chorioretinopathy.
Smretschnig E; Ansari-Shahrezaei S; Moussa S; Glittenberg C; Krebs I; Binder S
Retina; 2012; 32(10):2014-9. PubMed ID: 22466482
[TBL] [Abstract][Full Text] [Related]
5. Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone - a case report.
Venkatesh R; Pereira A; Jain K; Yadav NK
BMC Ophthalmol; 2020 Jun; 20(1):219. PubMed ID: 32503484
[TBL] [Abstract][Full Text] [Related]
6. Recurrent Central Serous Chorioretinopathy with Dexamethasone Eye Drop used Nasally for Rhinitis.
Prakash G; Shephali J; Tirupati N; Ji PD
Middle East Afr J Ophthalmol; 2013; 20(4):363-5. PubMed ID: 24339692
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Eplerenone in Chronic Central Serous Chorioretinopathy Refractory to Photodynamic Therapy.
Karagiannis D; Parikakis E; Kontomichos L; Batsos G; Chatziralli I
Semin Ophthalmol; 2019; 34(6):436-441. PubMed ID: 31309849
[No Abstract] [Full Text] [Related]
8. A case of adult-onset Still's disease presenting with multifocal central serous chorioretinopathy.
Liu T; Dong Y; Zeng DF; Xie L; Ye J; He XG
Eur Rev Med Pharmacol Sci; 2014; 18(3):421-5. PubMed ID: 24563445
[TBL] [Abstract][Full Text] [Related]
9. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
[TBL] [Abstract][Full Text] [Related]
10. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY-GUIDED PHOTODYNAMIC THERAPY FOR ACUTE CENTRAL SEROUS CHORIORETINOPATHY.
Hu J; Qu J; Li M; Sun G; Piao Z; Liang Z; Yao Y; Sadda S; Zhao M
Retina; 2021 Jan; 41(1):189-198. PubMed ID: 32343102
[TBL] [Abstract][Full Text] [Related]
11. [Photodynamic therapy in a patient with chronic central serous chorioretinopathy--a case report].
Pociej W; Karska-Basta I; Kolár L; Oleksy P; Romanowska-Dixon B
Klin Oczna; 2014; 116(1):28-31. PubMed ID: 25137918
[TBL] [Abstract][Full Text] [Related]
12. CLINICAL FEATURES OF FLAT IRREGULAR PIGMENT EPITHELIAL DETACHMENT ASSOCIATED WITH CHOROIDAL NEOVASCULARIZATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Guo J; Tang W; Liu W; Chang Q; Xu G
Retina; 2021 Jan; 41(1):199-207. PubMed ID: 32251241
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy.
Pichi F; Carrai P; Ciardella A; Behar-Cohen F; Nucci P;
Int Ophthalmol; 2017 Oct; 37(5):1115-1125. PubMed ID: 27757733
[TBL] [Abstract][Full Text] [Related]
14. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T
Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
[TBL] [Abstract][Full Text] [Related]
15. Long-term results and recurrence rates after spironolactone treatment in non-resolving central serous chorio-retinopathy (CSCR).
Herold TR; Rist K; Priglinger SG; Ulbig MW; Wolf A
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):221-229. PubMed ID: 27475933
[TBL] [Abstract][Full Text] [Related]
16. Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy.
Koytak A; Erol K; Coskun E; Asik N; Öztürk H; Özertürk Y
Retina; 2010; 30(10):1698-703. PubMed ID: 20539254
[TBL] [Abstract][Full Text] [Related]
17. Central Serous Chorioretinopathy: Morphological and Functional Outcome after Subthreshold Thermal Laser Coagulation with a Frequency-Doubled Nd:YAG Continuous-Wave Laser.
Enders C; Lang GE; Mayer B; Werner JU
Ophthalmologica; 2022; 245(1):59-68. PubMed ID: 34517369
[TBL] [Abstract][Full Text] [Related]
18. Topical Dexamethasone as an Adjuvant to Mineralocorticoid Receptor Antagonists for the Treatment of Recalcitrant Central Serous Chorioretinopathy.
Wong A; Zhu D; Li AS; Lee JG; Ferrone PJ
Ophthalmic Surg Lasers Imaging Retina; 2022 Dec; 53(12):659-665. PubMed ID: 36547963
[TBL] [Abstract][Full Text] [Related]
19. Multimodal imaging for the diagnosis of an atypical case of central serous chorioretinopathy.
Kahloun R; Chebbi A; Amor SB; Ksiaa I; Nacef L; Khairallah M
Middle East Afr J Ophthalmol; 2014; 21(4):354-7. PubMed ID: 25371645
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Efficacy and Safety of Photodynamic Therapy in Patients With Chronic Central Serous Chorioretinopathy.
Park YJ; Kim YK; Park KH; Woo SJ
Ophthalmic Surg Lasers Imaging Retina; 2019 Dec; 50(12):760-770. PubMed ID: 31877221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
